Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading

This viewpoint article critiques two recent articles examining ‘willingness to risk death’ to advance HIV cure-related research. The ‘willingness to risk death’ endpoint sends the wrong signal to the HIV cure-related research community about ongoing research in otherwise healthy volunteers living wi...

Full description

Bibliographic Details
Main Authors: Karine Dubé, Lynda Dee
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Journal of Virus Eradication
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020300212
id doaj-46687b0064c2431e9ffcc65bf4087341
record_format Article
spelling doaj-46687b0064c2431e9ffcc65bf40873412021-05-05T04:04:07ZengElsevierJournal of Virus Eradication2055-66402020-04-01628184Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleadingKarine Dubé0Lynda Dee1Public Health Leadership Program, UNC Gillings School of Global Public Health, Chapel Hill, NC, USA; Corresponding author: Karine Dubé, UNC Gillings School of Global Public Health, 4108 McGavran-Greenberg Hall, Chapel Hill, NC27599, USADelaney AIDS Research Enterprise Community Advisory Board (CAB), Baltimore, MD, USA; amfAR Institute for HIV Cure Research CAB, Baltimore, MD, USA; AIDS Action Baltimore, MD, USAThis viewpoint article critiques two recent articles examining ‘willingness to risk death’ to advance HIV cure-related research. The ‘willingness to risk death’ endpoint sends the wrong signal to the HIV cure-related research community about ongoing research in otherwise healthy volunteers living with HIV. Socio-behavioural scientists have examined the acceptability of a 99% risk of death scenario, which is unrealistic and would not be acceptable by current regulatory and ethical standards. We believe that the field needs robust and relevant socio-behavioural research reflecting ongoing biomedical HIV cure-related trials. These studies will need to withstand regulatory and ethical scrutiny if cure or remission regimens are to proceed to the licensing stage. The HIV cure-related research community must continue to protect the public trust in the HIV cure-related research field and sustain societal value generated by such research. We call for the utmost prudence in designing biomedical HIV cure trials as well as in setting up socio-behavioural research experiments related to these complex trials.http://www.sciencedirect.com/science/article/pii/S2055664020300212risk of deathwillingness to participate (WTP)HIV cure-related researchotherwise healthy volunteerssocio-behavioural research
collection DOAJ
language English
format Article
sources DOAJ
author Karine Dubé
Lynda Dee
spellingShingle Karine Dubé
Lynda Dee
Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
Journal of Virus Eradication
risk of death
willingness to participate (WTP)
HIV cure-related research
otherwise healthy volunteers
socio-behavioural research
author_facet Karine Dubé
Lynda Dee
author_sort Karine Dubé
title Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
title_short Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
title_full Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
title_fullStr Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
title_full_unstemmed Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
title_sort willingness to risk death endpoint in hiv cure-related research with otherwise healthy volunteers is misleading
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2020-04-01
description This viewpoint article critiques two recent articles examining ‘willingness to risk death’ to advance HIV cure-related research. The ‘willingness to risk death’ endpoint sends the wrong signal to the HIV cure-related research community about ongoing research in otherwise healthy volunteers living with HIV. Socio-behavioural scientists have examined the acceptability of a 99% risk of death scenario, which is unrealistic and would not be acceptable by current regulatory and ethical standards. We believe that the field needs robust and relevant socio-behavioural research reflecting ongoing biomedical HIV cure-related trials. These studies will need to withstand regulatory and ethical scrutiny if cure or remission regimens are to proceed to the licensing stage. The HIV cure-related research community must continue to protect the public trust in the HIV cure-related research field and sustain societal value generated by such research. We call for the utmost prudence in designing biomedical HIV cure trials as well as in setting up socio-behavioural research experiments related to these complex trials.
topic risk of death
willingness to participate (WTP)
HIV cure-related research
otherwise healthy volunteers
socio-behavioural research
url http://www.sciencedirect.com/science/article/pii/S2055664020300212
work_keys_str_mv AT karinedube willingnesstoriskdeathendpointinhivcurerelatedresearchwithotherwisehealthyvolunteersismisleading
AT lyndadee willingnesstoriskdeathendpointinhivcurerelatedresearchwithotherwisehealthyvolunteersismisleading
_version_ 1721475921045618688